Dissolvable Sutures Market
By Product Type;
Natural Dissolvable Sutures, Catgut Plain Sutures, Catgut Chromic Sutures, Synthetic Dissolvable Sutures, Polyglycolic Acid Sutures (PGA sutures) Coated and Braided Suture, Polyglactin 910 Sutures (PGLA sutures) Coated and Braided Suture, Poliglecaprone Sutures (PGCL sutures) Monofilament Suture, and Polydioxanone Sutures (PDS Sutures) Monofilament SutureBy Applications;
Cardiovascular Surgeries, General Surgeries, Gynecological Surgeries, Orthopedic Surgeries, Ophthalmic Surgeries, and OthersBy End User;
Ambulatory Surgical Centers, Hospital, Clinics, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Dissolvable Sutures Market Overview
Dissolvable Sutures Market (USD Million)
Dissolvable Sutures Market was valued at USD 1147.63 million in the year 2024. The size of this market is expected to increase to USD 1725.61 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.0%.
Dissolvable Sutures Market
*Market size in USD million
CAGR 6.0 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 6.0 % |
Market Size (2024) | USD 1147.63 Million |
Market Size (2031) | USD 1725.61 Million |
Market Concentration | Medium |
Report Pages | 308 |
Major Players
- Braun Melsungen AG
- Boston Scientific Corporation
- DemeTECH Corporation
- ENDOEVOLUTION
- Hu-Friedy Mfg Co
- Internacional Farmacutica S.A. De C.V
- Johnson & Johnson Services, Inc
- Medline Industries Inc
- Medtronic
- Pters Surgical
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Dissolvable Sutures Market
Fragmented - Highly competitive market without dominant players
The Dissolvable Sutures Market is expanding steadily, as more than 55% of operations now rely on absorbable options to simplify healing and reduce discomfort. These sutures dissolve naturally inside the body, eliminating the need for manual removal and supporting faster recovery. Their increasing adoption highlights a broader industry shift toward minimally invasive and patient-friendly solutions that align with modern care standards.
Material Innovations Enhancing Product Safety
Approximately 46% of emerging suture technologies are based on biodegradable materials that minimize immune reactions and optimize tissue healing. These synthetic polymers are part of a wave of technological innovations tailored to improve surgical results and reduce post-op risks. Companies are leveraging advanced materials to differentiate their offerings and strengthen their positions in a competitive surgical care market.
Regulatory Focus Driving Manufacturer Credibility
With over 50% of healthcare systems enforcing strict quality requirements, producers are emphasizing certified suture systems that follow global safety benchmarks. Training initiatives and support resources are being introduced to ensure proper handling and enhance clinical reliability. This emphasis on regulatory alignment is contributing to higher adoption rates and improved user satisfaction across the industry.
Smart Technology Redefining Surgical Closure
Around 45% of research efforts now target smart dissolvable sutures that feature sensors or medication-delivery coatings for better post-operative management. These products are at the forefront of personalized medicine, offering insights into wound healing and infection prevention. The future of this market is grounded in technological advancement, creating avenues for high-value innovation and sustained market expansion.
Dissolvable Sutures Market Recent Developments
-
In June 2023, Ethicon, part of Johnson & Johnson Medical Device Companies, announced the U.S. launch of the ProxiSure Suturing Device, a laparoscopic suturing tool that offers wrist-like maneuverability and features a curved needle for enhanced precision.
-
In April 2021, Dolphin Sutures introduced "TEFLENE," a new non-absorbable suture made from polytetrafluoroethylene (PTFE). This monofilament suture material offers a smooth texture and a very low friction coefficient, ideal for precise and gentle tissue handling.
Dissolvable Sutures Market Segment Analysis
The Dissolvable Sutures Market has been segmented by Product Type, Applications, End User and Geography.
Dissolvable Sutures Market, Segmentation by Product Type
The Dissolvable Sutures Market has been segmented by Product Type into Natural Dissolvable Sutures, Catgut Plain Sutures, Catgut Chromic Sutures, Synthetic Dissolvable Sutures, Polyglycolic Acid Sutures (PGA Sutures) - Coated And Braided Suture, Polyglactin 910 Sutures (PGLA Sutures) - Coated And Braided Suture, Poliglecaprone Sutures (PGCL Sutures) - Monofilament Suture and Polydioxanone Sutures (PDS Sutures) - Monofilament Suture.
Natural Dissolvable SuturesNatural dissolvable sutures are derived from biological sources such as collagen, primarily used in soft tissue approximation. These sutures offer excellent biocompatibility and are gradually absorbed by enzymatic activity. They are preferred in procedures where low tensile strength is sufficient, holding a market share of around 18%.
Catgut Plain SuturesCatgut plain sutures are a subtype of natural sutures made from purified collagen taken from the intestines of animals. They are used in tissues that heal quickly and dissolve within 7–10 days. This segment accounts for nearly 10% of the overall dissolvable sutures market.
Catgut Chromic SuturesCatgut chromic sutures are treated with chromic salt solutions to extend their tensile strength and absorption time. Widely used in urological and gynecological surgeries, this segment holds a market share of about 8%, driven by its prolonged support in healing tissues.
Synthetic Dissolvable SuturesSynthetic dissolvable sutures dominate the market due to their controlled degradation and lower tissue reactivity. These are engineered using polymers that degrade through hydrolysis, making them highly predictable. They account for over 64% of the total dissolvable suture market.
Polyglycolic Acid Sutures (PGA Sutures) - Coated and Braided SuturePolyglycolic acid sutures are coated and braided to enhance handling and reduce tissue drag. These sutures are popular in internal soft tissue procedures and offer excellent tensile strength for up to 14 days. This sub-segment represents around 15% of the synthetic sutures market.
Polyglactin 910 Sutures (PGLA Sutures) - Coated and Braided SuturePolyglactin 910 sutures are a widely adopted braided suture known for high knot security and predictable absorption. These are used in general surgery, ophthalmic, and gynecological procedures. The segment captures approximately 20% of the synthetic dissolvable sutures segment.
Poliglecaprone Sutures (PGCL Sutures) - Monofilament SuturePoliglecaprone sutures are monofilament synthetic sutures designed for short-term support and rapid absorption. Their smooth texture reduces infection risk and tissue trauma. They comprise around 12% of the synthetic dissolvable sutures category.
Polydioxanone Sutures (PDS Sutures) - Monofilament SuturePolydioxanone sutures offer extended wound support with absorption lasting up to 180 days. Commonly used in pediatric, cardiovascular, and gastrointestinal surgeries, they are known for their superior strength retention. This sub-segment holds nearly 17% of the synthetic sutures market.
Dissolvable Sutures Market, Segmentation by Applications
The Dissolvable Sutures Market has been segmented by Applications into Cardiovascular Surgeries, General Surgeries, Gynecological Surgeries, Orthopedic Surgeries, Ophthalmic Surgeries, and Others.
Cardiovascular SurgeriesThe use of dissolvable sutures in cardiovascular surgeries is critical due to the demand for precision and minimal foreign body reaction. These sutures offer reliable wound closure for delicate blood vessels and tissues. The segment contributes approximately 22% to the market owing to the rising prevalence of heart-related disorders and surgical interventions.
General SurgeriesGeneral surgeries represent a significant portion of the dissolvable sutures market, including procedures such as appendectomies, hernia repairs, and bowel resections. The broad application scope and rising number of surgeries worldwide drive this segment, which holds a market share of around 26%.
Gynecological SurgeriesDissolvable sutures are extensively used in gynecological procedures such as C-sections, hysterectomies, and pelvic repairs. Their absorbable nature eliminates the need for removal, reducing post-operative visits. This segment accounts for nearly 18% of the total market share.
Orthopedic SurgeriesIn orthopedic surgeries, dissolvable sutures are used for tendon repairs, ligament reconstruction, and fracture fixations. Their high tensile strength and gradual absorption support long healing durations. This application contributes to about 14% of the overall market.
Ophthalmic SurgeriesOphthalmic applications of dissolvable sutures include cataract and corneal surgeries, where precision and minimal tissue reaction are essential. Their use ensures optimal healing in delicate eye tissues. This segment holds a relatively smaller yet growing share of around 8%.
OthersThis category includes applications such as plastic surgeries, dental procedures, and pediatric surgeries. The rising demand for minimally invasive and cosmetic procedures has boosted the use of absorbable sutures in these areas, collectively accounting for approximately 12% of the market.
Dissolvable Sutures Market, Segmentation by End User
The Dissolvable Sutures Market has been segmented by End User into Ambulatory Surgical Centers, Hospital, Clinics and Others.
Ambulatory Surgical CentersAmbulatory surgical centers (ASCs) are increasingly adopting dissolvable sutures due to their role in same-day, minimally invasive procedures. These facilities benefit from the sutures' self-absorbing nature, which reduces the need for follow-up visits. The segment contributes around 20% to the overall market, driven by the rising volume of outpatient surgeries.
HospitalHospitals remain the leading end user of dissolvable sutures, owing to the wide range of surgical procedures performed, including emergency and critical care. Their comprehensive infrastructure and specialist availability make them a preferred setting. This segment dominates the market with a share of approximately 48%.
ClinicsClinics, especially specialty and day-care clinics, utilize dissolvable sutures in dermatological, dental, and minor surgical procedures. The convenience of suture absorption enhances the patient experience and minimizes revisits. Clinics account for about 17% of the market share.
OthersThis category includes research centers, veterinary practices, and home healthcare setups that apply dissolvable sutures in niche applications. Though comparatively smaller in volume, this segment is gradually expanding and holds nearly 15% of the total market.
Dissolvable Sutures Market, Segmentation by Geography
The Dissolvable Sutures Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Dissolvable Sutures Market Share (%), by Geographical Region
North America
North America holds the largest share of the dissolvable sutures market, accounting for approximately 35%. The region’s dominance is attributed to advanced healthcare infrastructure, high surgical volumes, and early adoption of biocompatible materials. The U.S. drives much of the demand, supported by favorable reimbursement policies and innovation in surgical suturing techniques.
Europe
Europe follows closely, contributing around 28% of the global market. The presence of leading medical device manufacturers, rising aging population, and the increasing rate of elective and cosmetic surgeries are key growth drivers. Countries like Germany, France, and the UK lead this regional demand.
Asia Pacific
Asia Pacific is the fastest-growing regional market, projected to witness a substantial rise in demand due to growing healthcare expenditure, expanding medical tourism, and an increasing patient base. The region currently holds a market share of about 20%, with India, China, and Japan at the forefront of adoption.
Middle East and Africa
The Middle East and Africa region holds a smaller share of the dissolvable sutures market, approximately 9%. Growth is driven by improving healthcare infrastructure and a rise in government healthcare investments. However, the market here remains nascent compared to more developed regions.
Latin America
Latin America represents about 8% of the global dissolvable sutures market. Increased access to healthcare services, along with a growing number of surgical interventions in Brazil, Mexico, and Argentina, supports steady market expansion. However, cost sensitivity and regulatory challenges may impact growth pace.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Dissolvable Sutures Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Growing Preference for Absorbable Wound Closure Solutions
- Rising Surgical Procedure Volumes Worldwide
- Advancements in Material Science and Biotechnology
-
Expanding Geriatric Population and Chronic Disease Burden: The expanding geriatric population and the increasing burden of chronic diseases worldwide significantly impact the global dissolvable sutures market. With aging comes a higher prevalence of chronic conditions such as cardiovascular diseases, diabetes, and orthopedic ailments, necessitating surgical interventions for disease management and treatment. As the geriatric demographic grows, there is a corresponding rise in the demand for surgical procedures, including joint replacements, cardiac surgeries, and various other interventions that require wound closure. Dissolvable sutures, known for their biocompatibility and gradual absorption, are particularly well-suited for use in older patients who may have slower wound healing processes and a higher risk of complications associated with non-absorbable sutures.
The prevalence of chronic diseases among younger age groups also contributes to the demand for surgical interventions and subsequent wound closure solutions. Conditions such as obesity, hypertension, and musculoskeletal disorders are increasingly affecting individuals at younger ages, leading to a higher volume of surgeries across various demographics. Dissolvable sutures offer advantages in terms of reduced risk of suture-related complications, enhanced patient comfort, and simplified postoperative care, making them a preferred choice in managing wounds in patients with chronic conditions. As the global population continues to age and the burden of chronic diseases rises, the demand for dissolvable sutures is expected to grow, driving market expansion and innovation in wound closure technologies.
Restraints
- Limited Availability of High-Quality Raw Materials
- Concerns Regarding Suture Strength and Tensile Properties
- High Cost of Advanced Dissolvable Suture Technologies
-
Challenges in Achieving Consistent Absorption Rates: One of the significant challenges facing the global dissolvable sutures market is the difficulty in achieving consistent absorption rates of sutures within the body. The absorption process of dissolvable sutures depends on various factors such as suture material, size, and the environment of the surgical site, which can vary among patients and surgical procedures. Variations in tissue pH, temperature, and blood supply can affect the rate of suture degradation and absorption, leading to inconsistencies in wound healing and potential complications. Achieving uniform absorption rates across different patients and surgical contexts is crucial to ensure predictable wound closure outcomes and minimize the risk of adverse reactions or tissue irritation.
The complexity of tissue biology and the dynamic nature of wound healing present additional challenges in achieving consistent absorption rates of dissolvable sutures. Factors such as inflammation, infection, and patient comorbidities can influence the healing process and alter the kinetics of suture degradation within the body. Additionally, the mechanical stresses exerted on sutures during wound closure and tissue movement can impact their integrity and absorption kinetics, further complicating the process. Addressing these challenges requires ongoing research and development efforts to optimize suture materials and designs, improve manufacturing processes, and enhance the understanding of tissue-suture interactions. By overcoming these challenges, manufacturers can ensure the reliability and effectiveness of dissolvable sutures in diverse clinical settings, ultimately improving patient outcomes and advancing the field of surgical wound management.
Opportunities
- Rising Adoption of Advanced Wound Closure Technologies
- Integration of Dissolvable Sutures into Minimally Invasive Surgical Instruments
- Collaboration with Healthcare Providers to Enhance Surgical Outcomes
-
Focus on Customization and Patient-Specific Solutions: The global dissolvable sutures market is witnessing a shift towards customization and the development of patient-specific solutions to address individual surgical needs and preferences. Healthcare providers increasingly recognize the importance of tailoring wound closure techniques and materials to meet the unique characteristics of each patient and surgical procedure. Customization involves considerations such as the type and location of the wound, the patient's age, health status, and lifestyle factors, as well as the surgeon's preferences and expertise. By offering a range of dissolvable suture options with varying properties such as absorption rates, tensile strength, and flexibility, manufacturers empower healthcare providers to select the most appropriate suture for each case, optimizing wound healing outcomes and patient satisfaction.
Advancements in technology, such as 3D printing and biomaterial engineering, enable the development of patient-specific dissolvable sutures tailored to individual anatomical and physiological needs. These innovative solutions allow for precise customization of suture dimensions, shapes, and compositions, enhancing compatibility with specific tissue types and surgical requirements. Additionally, customization extends beyond the physical attributes of the suture to encompass factors such as packaging, sterilization methods, and suture delivery systems, ensuring seamless integration into clinical workflows and enhancing overall surgical efficiency. By prioritizing customization and patient-specific solutions, the global dissolvable sutures market aims to improve surgical outcomes, minimize complications, and enhance the overall patient experience, driving innovation and growth in the field of surgical wound closure.
Competitive Landscape Analysis
Key players in Global Dissolvable Sutures Market include:
- Braun Melsungen AG
- Boston Scientific Corporation
- DemeTECH Corporation
- ENDOEVOLUTION
- Hu-Friedy Mfg Co
- Internacional Farmacutica S.A. De C.V
- Johnson & Johnson Services, Inc
- Medline Industries Inc
- Medtronic
- Pters Surgical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Applications
- Market Snapshot, By End User
- Market Snapshot, By Region
- Dissolvable Sutures Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Growing Preference for Absorbable Wound Closure Solutions
-
Rising Surgical Procedure Volumes Worldwide
-
Advancements in Material Science and Biotechnology
-
Expanding Geriatric Population and Chronic Disease Burden
-
- Restraints
-
Limited Availability of High-Quality Raw Materials
-
Concerns Regarding Suture Strength and Tensile Properties
-
High Cost of Advanced Dissolvable Suture Technologies
-
Challenges in Achieving Consistent Absorption Rates
-
- Opportunities
-
Rising Adoption of Advanced Wound Closure Technologies
-
Integration of Dissolvable Sutures into Minimally Invasive Surgical Instruments
-
Collaboration with Healthcare Providers to Enhance Surgical Outcomes
-
Focus on Customization and Patient-Specific Solutions
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Dissolvable Sutures Market, By Product Type, 2021 - 2031 (USD Million)
- Natural Dissolvable Sutures
- Catgut Plain Sutures
- Catgut Chromic Sutures
- Synthetic Dissolvable Sutures
- Polyglycolic Acid Sutures (PGA sutures) - Coated and Braided Suture
- Polyglactin 910 Sutures (PGLA sutures) - Coated and Braided Suture
- Poliglecaprone Sutures (PGCL sutures) - Monofilament Suture
- Polydioxanone Sutures (PDS Sutures) - Monofilament Suture
- Dissolvable Sutures Market, By Applications, 2021 - 2031 (USD Million)
- Cardiovascular Surgeries
- General Surgeries
- Gynecological Surgeries
- Orthopedic Surgeries
- Ophthalmic Surgeries
- Dissolvable Sutures Market, By End User, 2021 - 2031 (USD Million)
- Ambulatory Surgical Centers
- Hospital
- Clinics
- Dissolvable Sutures Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Dissolvable Sutures Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Braun Melsungen AG
- Boston Scientific Corporation
- DemeTECH Corporation
- ENDOEVOLUTION
- Hu-Friedy Mfg. Co
- Internacional Farmacutica S.A. De C.V
- Johnson & Johnson Services Inc
- Medline Industries Inc
- Medtronic
- Pters Surgical
- Company Profiles
- Analyst Views
- Future Outlook of the Market